DK1267847T3 - 5HT2-antagonist til regulering af IOP og behandling af glaucom - Google Patents
5HT2-antagonist til regulering af IOP og behandling af glaucomInfo
- Publication number
- DK1267847T3 DK1267847T3 DK00978627T DK00978627T DK1267847T3 DK 1267847 T3 DK1267847 T3 DK 1267847T3 DK 00978627 T DK00978627 T DK 00978627T DK 00978627 T DK00978627 T DK 00978627T DK 1267847 T3 DK1267847 T3 DK 1267847T3
- Authority
- DK
- Denmark
- Prior art keywords
- iop
- glaucoma
- antagonist
- regulation
- treatment
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title 1
- 239000003215 serotonin 5-HT2 receptor antagonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19028800P | 2000-03-17 | 2000-03-17 | |
| PCT/US2000/031246 WO2001070207A2 (fr) | 2000-03-17 | 2000-11-14 | Agonistes de 5ht2 permettant de commander la pression intra-oculaire elevee et de traiter le glaucome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1267847T3 true DK1267847T3 (da) | 2004-03-08 |
Family
ID=22700724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00978627T DK1267847T3 (da) | 2000-03-17 | 2000-11-14 | 5HT2-antagonist til regulering af IOP og behandling af glaucom |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1267847B1 (fr) |
| JP (1) | JP2003527415A (fr) |
| KR (1) | KR100499903B1 (fr) |
| CN (1) | CN1231214C (fr) |
| AR (1) | AR026707A1 (fr) |
| AT (1) | ATE258793T1 (fr) |
| AU (2) | AU2001216071B2 (fr) |
| BR (1) | BR0017158A (fr) |
| CA (1) | CA2401969A1 (fr) |
| DE (1) | DE60008151T2 (fr) |
| DK (1) | DK1267847T3 (fr) |
| ES (1) | ES2210018T3 (fr) |
| HK (1) | HK1050143A1 (fr) |
| MX (1) | MXPA02008548A (fr) |
| PL (1) | PL358296A1 (fr) |
| PT (1) | PT1267847E (fr) |
| TR (1) | TR200400424T4 (fr) |
| TW (1) | TW546139B (fr) |
| WO (1) | WO2001070207A2 (fr) |
| ZA (1) | ZA200206852B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6960579B1 (en) | 1998-05-19 | 2005-11-01 | Alcon Manufacturing, Ltd. | Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders |
| TW593302B (en) | 2001-12-20 | 2004-06-21 | Alcon Inc | Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| AU2003300915B2 (en) | 2002-12-13 | 2008-08-28 | Alcon, Inc. | Novel benzopyran analogs and their use for the treatment of glaucoma |
| US7476687B2 (en) * | 2003-11-26 | 2009-01-13 | Alcon, Inc. | Substituted furo[2,3-g]indazoles for the treatment of glaucoma |
| US7338972B1 (en) | 2003-12-15 | 2008-03-04 | Alcon, Inc. | Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma |
| TW200520760A (en) | 2003-12-15 | 2005-07-01 | Alcon Inc | Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma |
| US7129257B1 (en) | 2003-12-15 | 2006-10-31 | Alcon, Inc. | Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma |
| EP2400300A1 (fr) | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Procédé de sélection d'agents préventifs/remèdes pour l'incontinence de stress |
| US7425572B2 (en) | 2004-12-08 | 2008-09-16 | Alcon, Inc. | Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma |
| WO2007132841A1 (fr) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique fusionné et utilisation |
| JP5520051B2 (ja) | 2007-11-15 | 2014-06-11 | 武田薬品工業株式会社 | 縮合ピリジン誘導体およびその用途 |
| JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
| EP3733204A4 (fr) | 2017-12-27 | 2021-09-15 | Takeda Pharmaceutical Company Limited | Agent thérapeutique pour incontinence urinaire de stress et incontinence fécale |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3560986B2 (ja) * | 1997-01-13 | 2004-09-02 | 山之内製薬株式会社 | ５―ｈｔ２ｃ受容体作用薬及びアミノアルキルインダゾール誘導体 |
| WO2001040183A1 (fr) * | 1999-12-03 | 2001-06-07 | Alcon Universal Ltd. | 1-aminoalkyl-1 h-indoles pour traiter le glaucome |
-
2000
- 2000-11-14 EP EP00978627A patent/EP1267847B1/fr not_active Expired - Lifetime
- 2000-11-14 TR TR2004/00424T patent/TR200400424T4/xx unknown
- 2000-11-14 BR BR0017158-1A patent/BR0017158A/pt not_active IP Right Cessation
- 2000-11-14 CA CA002401969A patent/CA2401969A1/fr not_active Abandoned
- 2000-11-14 AU AU2001216071A patent/AU2001216071B2/en not_active Ceased
- 2000-11-14 MX MXPA02008548A patent/MXPA02008548A/es active IP Right Grant
- 2000-11-14 ES ES00978627T patent/ES2210018T3/es not_active Expired - Lifetime
- 2000-11-14 PL PL00358296A patent/PL358296A1/xx not_active Application Discontinuation
- 2000-11-14 KR KR10-2002-7012202A patent/KR100499903B1/ko not_active Expired - Fee Related
- 2000-11-14 JP JP2001568405A patent/JP2003527415A/ja active Pending
- 2000-11-14 PT PT00978627T patent/PT1267847E/pt unknown
- 2000-11-14 DK DK00978627T patent/DK1267847T3/da active
- 2000-11-14 DE DE60008151T patent/DE60008151T2/de not_active Expired - Fee Related
- 2000-11-14 CN CNB008193452A patent/CN1231214C/zh not_active Expired - Fee Related
- 2000-11-14 WO PCT/US2000/031246 patent/WO2001070207A2/fr active IP Right Grant
- 2000-11-14 AT AT00978627T patent/ATE258793T1/de not_active IP Right Cessation
- 2000-11-14 AU AU1607101A patent/AU1607101A/xx active Pending
- 2000-11-27 TW TW089125126A patent/TW546139B/zh not_active IP Right Cessation
- 2000-12-01 AR ARP000106393A patent/AR026707A1/es not_active Application Discontinuation
-
2002
- 2002-08-27 ZA ZA200206852A patent/ZA200206852B/en unknown
-
2003
- 2003-04-02 HK HK03102379A patent/HK1050143A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60008151D1 (de) | 2004-03-11 |
| MXPA02008548A (es) | 2004-08-23 |
| HK1050143A1 (en) | 2003-06-13 |
| WO2001070207A2 (fr) | 2001-09-27 |
| CN1231214C (zh) | 2005-12-14 |
| KR100499903B1 (ko) | 2005-07-07 |
| EP1267847B1 (fr) | 2004-02-04 |
| ES2210018T3 (es) | 2004-07-01 |
| PT1267847E (pt) | 2004-05-31 |
| BR0017158A (pt) | 2003-06-03 |
| AU2001216071B2 (en) | 2004-12-02 |
| PL358296A1 (en) | 2004-08-09 |
| JP2003527415A (ja) | 2003-09-16 |
| AU1607101A (en) | 2001-10-03 |
| TW546139B (en) | 2003-08-11 |
| ZA200206852B (en) | 2003-08-27 |
| CN1450897A (zh) | 2003-10-22 |
| WO2001070207A3 (fr) | 2002-05-10 |
| ATE258793T1 (de) | 2004-02-15 |
| CA2401969A1 (fr) | 2001-09-27 |
| KR20030095185A (ko) | 2003-12-18 |
| DE60008151T2 (de) | 2004-07-08 |
| EP1267847A2 (fr) | 2003-01-02 |
| AR026707A1 (es) | 2003-02-26 |
| TR200400424T4 (tr) | 2004-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1112106T3 (da) | Serotonerge 5HT2-agonister til behandling af glaukom | |
| NO20035609L (no) | Fremgangsmate for kontinuerlig naftabehandling | |
| DK1343773T3 (da) | Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser | |
| DK1379224T3 (da) | Guanylat-cyclase receptor-agonister til behandling af vævsinflammation og carciogenese | |
| DK1562932T3 (da) | 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter | |
| DE60215179D1 (de) | Dolastatin 10 derivate | |
| DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
| DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
| DK1392292T3 (da) | Pyranoindazoler og deres anvendelse til behandling af glaukom | |
| DK1411926T3 (da) | Integrininhibitorer til behandling af öjensygdomme | |
| GB2402674B (en) | Compositions and methods for the treatment of glaucoma or ocular hypertension | |
| DK1267847T3 (da) | 5HT2-antagonist til regulering af IOP og behandling af glaucom | |
| NO20034123L (no) | Fremgangsmåte for behandling av brennstoff | |
| MXPA03003741A (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. | |
| DK1344526T3 (da) | Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser | |
| DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
| DK1309322T3 (da) | Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser | |
| EP1558238A4 (fr) | Beta-hydroxyphenylaldylamines et utilisation de celles-ci pour traiter le glaucome | |
| EP1455780A4 (fr) | Nouveaux derives de benzodifurane imidazoline et de benzofurane imidazoline et leur utilisation pour traiter le glaucome | |
| DK1257278T3 (da) | Anvendelse af mirtazapin til behandling af sövnforstyrrelser | |
| NO20035043D0 (no) | Fremgangsmåte for behandling av okular hypertensjon og glaukom | |
| ATE443060T1 (de) | Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit | |
| DK1225890T3 (da) | Rivastigmin til behandling af öjensygdomme | |
| NO20025760L (no) | S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser | |
| NO20024381D0 (no) | Behandling av okular hypertensjon og gluakom |